Michael Gaffney

CEO & President at Cellphire Therapeutics

Mr. Gaffney has deep health sector insight, extensive operational experience, and proven strategy and capital markets expertise. His 30-year career includes serving in executive leadership positions, including as Executive Chairman and interim CEO for over 10 healthcare organizations. In these roles, he oversaw and contributed to strategy development and execution, talent recruitment, business development, growth, and capital raising.

Prior to joining Cellphire, Mr. Gaffney founded Bancroft Group, LLC, a strategy and operational consulting business focused on middle market companies and their investors. In addition to founding Bancroft Group, he is a co-founder of EDG Partners, LLC, a healthcare-focused private equity firm. Prior to Bancroft Group and EDG Partners, Mr. Gaffney was a partner at Allied Capital (NYSE: ALD) where he led the healthcare investment strategy. Before joining Allied, he was a consultant at McKinsey & Co., Inc. Mr. Gaffney also served in the U.S. Navy as a Submarine Officer.

Mr. Gaffney received a Master of Arts from Oxford University, where he was a Rhodes Scholar, and a Bachelor of Science from the United States Naval Academy, where he serves on the A&S Board of Trustees.

Links

Previous companies

PWNHealth logo

Timeline

  • CEO & President

    April, 2021 - present

View in org chart